Exhale

The official blog of the Lung Institute.

Your Doctor won’t Recommend Cellular Treatments for Your COPD. But, They Should

22 Nov 2017
| Under COPD, Disease Education, Lung Disease | Posted by | 4 Comments
Why_Dont_Doctors_Recommend

The medical treatment world is a fast-evolving world where today’s miracle treatment may be tomorrow’s quackery.

Doctors are constantly bombarded with drugs and treatments that claim to cure what ails you. So, how does a doctor decide what is the right remedy?

Lung Institute Success Rate

The Lung Institute’s cellular therapy addresses the progression of diseases such as COPD, emphysema, chronic bronchitis, pulmonary fibrosis and others.

We have treated thousands of patients and have a remarkable success rate with more than 84 percent of our patients reporting an improved quality of life within three months of treatment.

Yet, many doctors won’t recommend cellular therapy to their patients suffering from lung diseases.

Why not, if data outcomes show many patients have shown noticeable improvement?

Doctors Like Traditional Medicine

Most doctors aren’t going to recommend anything that is not considered traditional medicine, especially when the treatment is not yet covered by insurance.

Generally, doctors practice traditional medicine and are very statistical. Even though there are many advancements in the field of regenerative medicine, many doctors are still skeptical.

Our cellular therapy is a treatment, not a drug.

That is also an issue for doctors.

Since it is not a drug, our treatments are not approved by the Food and Drug Administration (FDA).

Again, many doctors will not recommend something that does not have FDA approval.

We address this by doing the next best thing to having FDA approval.

We operate under current FDA guidelines and regulations 1271.10 and 1271.15.

The Lung Institute complies with all necessary requirements for operation.

The Lung Institute is firmly in accordance with the conditions set by the FDA for exemption status and conducts itself in full accordance with current guidelines.

Many now widely accepted treatments were slow to gain acceptance.

For example, bone marrow transplants (hematopoietic cells) have been around for more than 50 years, but they weren’t accepted in the early years.

As more and more success stories were revealed, it became a more standard procedure.

In the early 1970’s, there were only a few hundred transplants being done each year.

It slowly increased to about 5,000 in 1985 and 10,000 in 1995.

Then it took off, with more than 40,000 transplants reported in 2000.

Most doctors are not early adopters, but prefer to wait for more mainstream acceptance.

It’s Your Decision, Not Your Doctors

Your doctor or specialist should be a sounding board for helping you decide whether to pursue cellular therapy to treat your lung disease, but they should not be the ultimate decision maker for you.

This is your private and personal decision.

If your doctor is skeptical, ask them why.

Is it based on their research or just a feeling?

Our doctors and medical staff are constantly researching, updating treatments and improving treatment protocols based on research.

The Lung Institute aims to deliver the highest quality of care for our patients as well as continually improve our treatments for our patients.

We have published a White Paper with our latest findings, which you can find on our resources page.

One of our recent testimonials discussed the role a doctor played in influencing a patient’s decision to undergo our cellular procedure.

Once you have made the decision to have our cellular procedure, your doctor can continue to play a vital role.

Make sure they help you get the proper tests and monitor your progress.

If you or a loved one suffers from COPD or another lung disease, the Lung Institute may be able to help with a variety of cellular therapy options.

Contact us at (800) 729-3065 today to find out if you qualify for cellular therapy.

The Lung Institute supports November as National COPD Awareness Month sponsored by the US COPD Coalition.

November 15 is designated as World COPD Awareness Day.

* Every patient is given a Patient Satisfaction Survey shortly after treatment. Responses to the 11-question survey are aggregated to determine patient satisfaction with the delivery of treatment.

^ Quality of Life Survey data measured the patient’s self-assessed quality of life and measurable quality of improvement at three months.

All claims made regarding the efficacy of Lung Institute's treatments as they pertain to pulmonary conditions are based solely on anecdotal support collected by Lung Institute. Individual conditions, treatment and outcomes may vary and are not necessarily indicative of future results. Testimonial participation is voluntary. Lung Institute does not pay for or script patient testimonials.

As required by Texas state law, the Lung Institute Dallas Clinic has received Institutional Review Board (IRB) approval from MaGil IRB, now Chesapeake IRB, which is fully accredited by the Association for the Accreditation of Human Research Protection Program (AAHRPP), for research protocols and procedures. The Lung Institute has implemented these IRB approved standards at all of its clinics nationwide. Approval indicates that we follow rigorous standards for ethics, quality, and protections for human research.

Each patient is different. Results may vary.